[Precautionary measures in the use of colloidal whole blood substitutes].
D000937:Antigen-Antibody Reactions; D003102:Colloids; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000517:prevention & control; D004417:Dyspnea / Q000139:chemically induced; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006636:Histamine Release; D007022:Hypotension / Q000139:chemically induced; D010952:Plasma Substitutes / Q000009:adverse effects*; D011239:Prednisolone / Q000627:therapeutic use; D012151:Resuscitation; D012769:Shock / Q000139:chemically induced; D013610:Tachycardia / Q000139:chemically induced
D003102:Colloids; D006634:Histamine H1 Antagonists; D010952:Plasma Substitutes; D011239:Prednisolone
Vorsichtsmabetanahmen bei der Anwendung von kolloidalen Vollblutersatzmitteln